News about "Cancer Treatment"

Layered Nanoparticle Platform Could Expand Targeted Radioisotope Cancer Therapies

Scientists have developed a specialised nanoplatelet that rapidly captures and strongly retains radioisotopes, potentially creating a versatile platform for targeted cancer imaging, radionuclide therapy and theranostic applications.

Cancer Treatment | 19/08/2026 | By News Bureau

Innovent and Daiichi Sankyo Partner for Vanflyta Commercialisation in China

Innovent Biologics and Daiichi Sankyo have entered an exclusive agreement to commercialise Vanflyta in China, expanding access for FLT3-ITD positive AML patients.

Cancer Treatment | 11/08/2026 | By News Bureau

UK MHRA Approves Retifanlimab for Merkel Cell Skin Cancer

The UK MHRA has approved retifanlimab (ZYNYZ) for the treatment of advanced Merkel Cell Carcinoma (MCC), a rare and aggressive skin cancer with significant unmet medical need.

Cancer Treatment | 08/07/2026 | By Akanki |  114

US FDA Approves Pfizer's Ibrance for Maintenance Treatment of HR+, HER2+ Metastatic Breast Cancer

FDA approval makes Ibrance the first CDK4/6 inhibitor indicated for HR+ metastatic breast cancer regardless of HER2 status.

Cancer Treatment | 26/06/2026 | By News Bureau |  262

US FDA Approves KEYTRUDA and KEYTRUDA QLEX, Each with Trodelvy

The US Food and Drug Administration (FDA) has approved KEYTRUDA and KEYTRUDA QLEX in combination with Trodelvy as first-line treatment for adults with PD-L1-positive (CPS ≥10) advanced Triple-Negative Breast Cancer (TNBC).

Cancer Treatment | 26/06/2026 | By News Bureau |  203

Novartis Reports Strong Long-Term Efficacy of Scemblix in Chronic Myeloid Leukemia Trial

Novartis’ Scemblix demonstrated sustained efficacy and a favourable safety profile over nearly three years of follow-up, reinforcing its potential as a frontline treatment option for adults with Philadelphia chromosome-positive chronic myeloid leukemia.

Cancer Treatment | 03/06/2026 | By News Bureau |  140

Onco-Innovations Subsidiary Partners with GSK on Real-World Oncology Data Research

Inka Health and GSK will collaborate to develop real-world data methodologies aimed at improving the applicability of oncology clinical trial findings across diverse patient populations and healthcare settings.

Cancer Treatment | 07/05/2026 | By News Bureau |  138

Merck Completes USD 5.8 Billion Acquisition of Terns Pharmaceuticals to Strengthen Oncology Pipeline

Merck acquires Terns Pharmaceuticals, advancing development of next-generation therapies for chronic myeloid leukaemia.

Cancer Treatment | 06/05/2026 | By News Bureau |  146

IMUNON Reports Phase 2 Data Showing Improved Survival in Advanced Ovarian Cancer

IMUNON reports updated Phase 2 data showing improved Overall Survival (OS) with IMNN-001 in advanced ovarian cancer.

Cancer Treatment | 26/03/2026 | By News Bureau |  159

Zydus Launches World's First Nivolumab Biosimilar 'Tishtha' in India

Zydus Lifesciences has launched Tishtha, the world’s first biosimilar of the immunotherapy drug nivolumab, in India, aimed at expanding access to advanced cancer care by offering the treatment at nearly one-fourth the cost of the reference product for patients with multiple cancer types.

Cancer Treatment | 23/01/2026 | By News Bureau |  1146